Aripiprazole-Induced Cutaneous Lupus Skin Rash with Test Results

Drug-induced skin rashes are a frequent yet often overlooked adverse reaction. Aripiprazole, an atypical antipsychotic, has been associated with various dermatological reactions, though reports of Cutaneous Lupus Erythematosus (CLE) remain scarce. We present a case of a 38-year-old male with an acute psychotic episode who developed a butterfly rash 10 days after initiating aripiprazole treatment. Extensive investigations, including serological markers for lupus, were negative. The rash resolved within 20 days of discontinuing aripiprazole, supporting the diagnosis of drug-induced CLE. This case highlights the diagnostic challenge of differentiating drug-induced lupus from primary dermatological conditions, particularly in psychiatric patients with multiple medication changes. Given the limited literature on aripiprazole-induced CLE, this report underscores the need for increased clinical awareness and thorough evaluation of unexplained dermatological reactions in patients receiving antipsychotics. Early recognition and prompt discontinuation of the offending drug are crucial in preventing unnecessary interventions and ensuring optimal patient care. Keywords: Antipsychotic Agents, Aripiprazole, Cutaneous, Drug-induced, Lupus Erythematosus

Authors

Publication Details

Journal
Journal of the Bahrain Medical Society
Published
2025-01-01
DOI
https://doi.org/10.26715/jbms.37_1_4
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Aripiprazole-Induced Cutaneous Lupus Skin Rash with Test Results

Amani Ali Amer, Mohamed Ahmed Alnafaiei
Journal of the Bahrain Medical Society
Systemic Lupus Erythematosus Research
article

Aripiprazole-Induced Cutaneous Lupus Skin Rash with Test Results

Amani Ali Amer, Mohamed Ahmed Alnafaiei
article en

Abstract

Drug-induced skin rashes are a frequent yet often overlooked adverse reaction. Aripiprazole, an atypical antipsychotic, has been associated with various dermatological reactions, though reports of Cutaneous Lupus Erythematosus (CLE) remain scarce. We present a case of a 38-year-old male with an acute psychotic episode who developed a butterfly rash 10 days after initiating aripiprazole treatment. Extensive investigations, including serological markers for lupus, were negative. The rash resolved within 20 days of discontinuing aripiprazole, supporting the diagnosis of drug-induced CLE. This case highlights the diagnostic challenge of differentiating drug-induced lupus from primary dermatological conditions, particularly in psychiatric patients with multiple medication changes. Given the limited literature on aripiprazole-induced CLE, this report underscores the need for increased clinical awareness and thorough evaluation of unexplained dermatological reactions in patients receiving antipsychotics. Early recognition and prompt discontinuation of the offending drug are crucial in preventing unnecessary interventions and ensuring optimal patient care. Keywords: Antipsychotic Agents, Aripiprazole, Cutaneous, Drug-induced, Lupus Erythematosus

Journal of the Bahrain Medical SocietyVol. 37(1)
Openalex Percentile: Top 90%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Aripiprazole-Induced Cutaneous Lupus Skin Rash with Test Results — Amani Ali Amer, Mohamed Ahmed Alnafaiei · Journal of the Bahrain Medical Society (2025) | TGRS Research Map | TGRS